Pyrimethamine
规格
58-14-0CAS 号
200-364-2EC 号
5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamineIUPAC 名称
C12H13ClN4化学式
248.71 g/mol分子量
pyrimethamine; 58-14-0; Daraprim; Chloridine; 5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine; Chloridin; Diaminopyritamin; Ethylpyrimidine; Pirimecidan; Pirimetamin; Pirimetamina; Chloridyn; Darachlor; Erbaprelina; Khloridin; Tindurin; Malocid; Primethamine; Pyrimethamin; 5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE; Pyrimethaminum; 2,4-Pyrimidinediamine, 5-(4-chlorophenyl)-6-ethyl-; Pyremethamine; 2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine; 2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine; TCMDC-125860; RP 4753; 2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine; BW 50-63; NCI-C01683; 5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine; NSC-3061; GNF-Pf-5586; DTXSID9021217; WR 2978; 5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine; 4753 R.P.; NSC 3061; WR-2978; CHEBI:8673; Z3614QOX8W; 2,4-Pyrimidinediamine, 5-(p-chlorophenyl)-6-ethyl-; NSC3061; Pyrimidine, 2,4-diamino-5-(p-chlorophenyl)-6-ethyl-; RP-4753; DTXCID601217; 5-25-12-00255 (Beilstein Handbook Reference); RefChem:55950; P01BD01; 200-364-2; Malocide; Darapram; Daraprime; Malacid; Maloprim; MFCD00057350; TCMDC-123831; CHEMBL36; 5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE; MLS000028606; MLS002701881; Daraclor; 5-(4-chlorophenyl)-6-ethyl-pyrimidine-2,4-diamine; CAS-58-14-0; NCGC00016256-08; SMR000058714; Tinduring; Pirimetamina [Spanish]; S2006; CP6; Pirimetamina [INN-Spanish]; Pyrimethaminum [INN-Latin]; BRD9204; BRD-9204; Daraprim (TN); CCRIS 546; Pyrimethamine (Pyr); SR-01000003150; EINECS 200-364-2; BRN 0219864; UNII-Z3614QOX8W; CRL-8131 & Pyrimethamine; CRL-8142 & Pyrimethamine; Lactoferrin B & Pyrimethamine; Lactoferrin H & Pyrimethamine; AI3-25005; Pyrimethamine (JAN/USP/INN); Pyrimethamine RS; HSDB 8042; EXR-101; Pyrimethamine CRS; Pyrimethamine [USP:INN:BAN:JAN]; Prestwick_504; BW 5063; Daraclor (Salt/Mix); Spectrum_000906; 4km0; CPD000058714; Pyrimethamine (Standard); Opera_ID_1437; Prestwick0_000037; Prestwick1_000037; Prestwick2_000037; Prestwick3_000037; Spectrum2_000886; Spectrum3_001701; Spectrum4_000494; Spectrum5_001447; PYRIMETHAMINE [MI]; Epitope ID:613391; PYRIMETHAMINE [INN]; PYRIMETHAMINE [JAN]; cid_4993; NCIOpen2_008313; PYRIMETHAMINE [IARC]; BIDD:PXR0173; SCHEMBL25129; BSPBio_000133; BSPBio_003282; KBioGR_001007; KBioSS_001386; PYRIMETHAMINE [VANDF]; MLS001148621; MLS002454446; BIDD:GT0149; DivK1c_000652; PYRIMETHAMINE [MART.]; SPECTRUM1500520; SPBio_000672; SPBio_002054; PYRIMETHAMINE [USP-RS]; PYRIMETHAMINE [WHO-DD]; PYRIMETHAMINE [WHO-IP]; BPBio1_000147; GTPL4800; orb1224596; orb1310237; SCHEMBL29381161; BDBM18512; HMS502A14; KBio1_000652; KBio2_001386; KBio2_003954; KBio2_006522; KBio3_002502; MSK7147; NINDS_000652; Pirimecidan;Pirimetamin;RP 4753; GLXC-07764; HMS1568G15; HMS1920N12; HMS2092E13; HMS2095G15; HMS2235A17; HMS3259C04; HMS3371L07; HMS3655D09; HMS3675P11; HMS3712G15; HMS3743O05; HMS3871I03; HMS5080P13; Pharmakon1600-01500520; PYRIMETHAMINE [GREEN BOOK]; PYRIMETHAMINE [ORANGE BOOK]; 2, 5-(p-chlorophenyl)-6-ethyl-; PXB93699; 2, 5-(4-chlorophenyl)-6-ethyl-; MSK7147-1000AD; PYRIMETHAMINE [EP MONOGRAPH]; Tox21_110332; Tox21_201834; Tox21_300129; CCG-39626; EBC-00583; HY-18062R; MSK7147-100A; NSC757306; PYRIMETHAMINE [USP MONOGRAPH]; PYRIMETHAMINUM [WHO-IP LATIN]; AKOS015892534; FANSIDAR COMPONENT PYRIMETHAMINE; Tox21_110332_1; AB02313; AC-7879; CS-1717; DB00205; FP27346; KS-5223; NC00528; NSC-757306; IDI1_000652; NCGC00016256-01; NCGC00016256-02; NCGC00016256-03; NCGC00016256-04; NCGC00016256-05; NCGC00016256-06; NCGC00016256-07; NCGC00016256-09; NCGC00016256-10; NCGC00016256-11; NCGC00016256-12; NCGC00016256-13; NCGC00016256-14; NCGC00016256-16; NCGC00016256-17; NCGC00016256-26; NCGC00023188-03; NCGC00023188-04; NCGC00023188-05; NCGC00023188-06; NCGC00023188-07; NCGC00254199-01; NCGC00259383-01; WLN: T6N CNJ BZ DZ ER DG& F2; HY-18062; NCI60_002604; SBI-0051500.P003; DB-053158; AB00052084; NS00001824; P2037; SW196698-3; C07391; D00488; EN300-118717; MLS-0002822.0001; AB00052084-21; AB00052084_22; AB00052084_25; 2,4-diamino-5(4-chlorophenyl)-6-ethylpyrimidine; F211965; L000713; Pyrimethamine Solution in Acetonitrile, 100ug/mL; Pyrimethamine, VETRANAL(TM), analytical standard; Pyrimidine,4-diamino-5-(p-chlorophenyl)-6-ethyl-; Q421072; 2,4,-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine; 2,4-diamino-5-(4-chloro-phenyl)-6-ethylpyrimidine; 2,4-diamino-6-ethyl-5-(4-chlorophenyl)pyrimidine; SR-01000003150-2; SR-01000003150-4; BRD-K88429204-001-05-4; BRD-K88429204-001-18-7; BRD-K88429204-001-21-1; BRD-K88429204-001-33-6; BRD-K88429204-001-34-4; BRD-K88429204-001-35-1; BRD-K88429204-001-36-9; Pyrimethamine Solution in Acetonitrile/DMSO, 1000ug/mL; Z1515385085; Pyrimethamine, European Pharmacopoeia (EP) Reference Standard; Pyrimethamine, United States Pharmacopeia (USP) Reference Standard同义词
